- Home
- MRNA vs RIVN Comparison
MRNA vs RIVN Comparison
Compare MRNA & RIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | RIVN |
|---|---|---|
| Founded | 2010 | 2009 |
| Country | United States | United States |
| Employees | N/A | 15232 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6B | 19.5B |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MRNA | RIVN |
|---|---|---|
| Price | $48.37 | $13.39 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 21 |
| Target Price | ★ $34.27 | $17.74 |
| AVG Volume (30 Days) | 7.0M | ★ 22.2M |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.77 | ★ 34.54 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,263,000,000.00 | $5,387,000,000.00 |
| Revenue This Year | $9.36 | $36.51 |
| Revenue Next Year | $15.43 | $63.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 4.29 | ★ 8.39 |
| 52 Week Low | $22.28 | $11.57 |
| 52 Week High | $59.55 | $22.69 |
Technical Indicators
Market Signals| Indicator | MRNA | RIVN |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 32.87 |
| Support Level | $46.30 | $12.50 |
| Resistance Level | $55.36 | $13.64 |
| Average True Range (ATR) | 3.63 | 0.59 |
| MACD | 0.03 | -0.19 |
| Stochastic Oscillator | 30.44 | 4.37 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About RIVN Rivian Automotive Inc.
Rivian is a battery electric vehicle automaker that sells its vehicles in the US and Canada. The company also develops electronic control units and related software for autos in a joint venture with Volkswagen. Rivian has multiple vehicles in its fleet, which include a luxury truck and full-size SUV and a delivery van. The company plans to begin selling a midsize SUV in 2026. Total deliveries were over 42,000 in 2025. Rivian is also developing autonomous driving software to be used in its vehicles and for robotaxis on the Uber ride-hailing network.